Allan Shaw

Mr. Allan L.
Shaw, CPA, is an Independent Director at CalciMedica, Inc., a Member at Corporate Directors Group, a Member at New York State Society of Certified Public Accountants and a Member at The American Institute of Certified Public Accountants.
He is on the Board of Directors at Evecxia, Inc., CalciMedica, Inc. and Edith & Carl Marks Jch of Bensonhurst.
Mr. Shaw was previously employed as a Chief Financial Officer by Alpha Compute Corp., an Independent Non-Executive Director by Blue Water Vaccines, Inc., a Chief Financial Officer, Secretary & Treasurer by Syndax Pharmaceuticals, Inc., an Independent Director by VIVUS, Inc., an Independent Director by Celsus Therapeutics Plc, an Independent Director by Akari Therapeutics Plc, a Managing Director by Alvarez & Marsal LLC, a Chief Financial Officer & Executive Director by NewLead Holdings Ltd., a Senior Managing Director by Shaw Strategic Capital LLC, a Chief Financial Officer by Serono SA, a Manager by Deloitte & Touche LLP, and a Chief Financial Officer by Merck Serono SA. He also served on the board at CalciMedica Subsidiary, Inc., Central New York Biotech Accelerator, Navios Maritime Holdings, Inc. and Viatel, Inc. He received his undergraduate degree from State University of New York College at Oswego.